Ambu A/S (AMBFF)
12.75
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
Ambu EPS Diluted (Quarterly): 0.0675 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.7044 |
| Genmab A/S | 0.6431 |
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
| IO Biotech, Inc. | -0.1252 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.01M |
| Revenue (Quarterly) | 229.53M |
| Total Expenses (Quarterly) | 211.52M |
| Enterprise Value | 3.348B |
| Gross Profit Margin (Quarterly) | 59.96% |
| Profit Margin (Quarterly) | 7.84% |
| Earnings Yield | 2.63% |
| Operating Earnings Yield | 3.39% |
| Normalized Earnings Yield | 2.631 |